Monoclonal Antibodies for COVID-19
Monoclonal antibodies are used to prevent or treat disease with targeted proteins. Hackensack Meridian Health is using these treatments at multiple sites across the health network for the prevention or treatment of COVID-19 under current scientific guidelines.
Monoclonal Antibodies for the Prevention of COVID-19
Hackensack Meridian Health is administering EVUSHELD for the prevention of COVID-19 in certain adults and children. Not everyone is eligible for EVUSHELD. Patients must meet certain criteria for EVUSHELD, including:
- Not currently being infected with COVID-19 and have not had recent known close contact with someone infected with COVID-19; and
- Are moderately to severely immunocompromised due to a medical condition or immunosuppressive medicines; or
- Are not recommended to receive the COVID-19 vaccine due to a history of severe adverse reaction.
Interested patients should speak with their providers about EVUSHELD to see if they qualify. Only providers can request EVUSHELD. Patients cannot request the therapy on their own.
EVUSHELD therapy is available for eligible patients at the following Hackensack Meridian Health locations:
- Hackensack University Medical Center
- JFK University Medical Center
- Jersey Shore University Medical Center
Monoclonal Antibodies for the Treatment of COVID-19
There are monoclonal antibody therapies available for the treatment of COVID-19. If you have COVID-19, your physician can refer you to an HMH hospital to determine whether you would benefit from this treatment.
Hackensack University Medical Center: The hospital has a dedicated monoclonal antibody treatment team located on site. Hackensack follows the guidelines and criteria for screening and treatment of these patients. Treatment occurs 8 a.m. to 5 p.m. Monday through Friday.
Pascack Valley Medical Center: All patients with COVID-19 who are seen at the emergency room are evaluated for monoclonal antibody use as per the guidelines. Patients who meet those criteria will be infused in the emergency room and then discharged home with appropriate instructions.
Palisades Medical Center: At Palisades, clinicians evaluate all of these patients in the emergency room.
Mountainside Medical Center: Mountainside Medical Center is administering monoclonal antibodies in its outpatient population who meet the criteria. Monoclonal antibody treatment is available in the hospital’s Emergency Department 24 hours a day, 7 days a week. Patients can make a virtual care appointment with Mountainside Medical Group by visiting mountainsidehosp.com/virtualcare to see if they qualify. For more information about monoclonal drug therapy to treat COVID-19, please visit mountainsidehosp.com/coronavirus and consult the heading “Drug Therapy FAQ.”
JFK University Medical Center: With a dedicated infusion center, JFK is following the criteria and treating those patients 8 a.m. to 5 p.m. Monday through Friday.
Jersey Shore University Medical Center: Eligible patients will be scheduled for screening and infusion in the emergency room within 24 hours of referral.
Riverview Medical Center: Riverview follows the guidelines and criteria for screening and treatment of these patients. Treatment is provided Tuesday, Wednesday and Thursday by appointment.
Ocean Medical Center: All patients with COVID-19 who are seen at the emergency room are evaluated for monoclonal antibody use as per the guidelines. Patients who meet criteria will be infused and then discharged home with appropriate instructions.
Southern Ocean Medical Center: All patients with COVID-19 who are seen at the emergency room are evaluated for monoclonal antibody use as per the guidelines. Patients who meet those criteria will be infused and then discharged home with appropriate instructions.